Press Release - news.vrtx.com
Dec 20, 2024 · Vertex Pharmaceuticals Incorporated Investors: [email protected] Susie Lisa, CFA: +1 617-341-6108 or Manisha Pai: +1 617-961-1899 Media: [email protected] or U.S.: 617-341-6992 Heather Nichols: +1 617-839-3607 or International: +44 20 3204 5275 Source: Vertex Pharmaceuticals Incorporated
Vertex Announces Results From Phase 2 Study of Suzetrigine for …
Dec 19, 2024 · BOSTON -- (BUSINESS WIRE)--Dec. 19, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy (LSR).
Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News ...
Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.
Press Releases - Vertex Pharmaceuticals Newsroom
Dec 8, 2024 · BOSTON --(BUSINESS WIRE)--Oct. 10, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET .
Vertex Pharmaceuticals (VRTX) News Today - MarketBeat
5 days ago · What's going on at Vertex Pharmaceuticals (NASDAQ:VRTX)? Read today's VRTX news from trusted media outlets at MarketBeat.
News & Events - Vertex Pharmaceuticals
Jul 30, 2024 · Suzetrigine has the potential to be the first new class of medicine to treat acute pain in over twenty years. The FDA has granted suzetrigine priority review and assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025.
Vertex Pharmaceuticals Incorporated (VRTX) Stock Price, News, …
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
News & Events - Vertex Pharmaceuticals
Mar 21, 2024 · BOSTON -- (BUSINESS WIRE)--Mar. 21, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for VX-407, an investigational first-in-class small molecule corrector that targets the …
News & Events - Vertex Pharmaceuticals
Feb 5, 2024 · To access the call, please dial (833) 630-2124 (U.S.) or +1(412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call.” The conference call will be webcast live and a link to the webcast can be accessed through Vertex 's website at www.vrtx.com in the "Investors" section. To ensure a timely ...
Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.